Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 379, Issue 1, 2009, Pages 61-72

  Moranta, David ^a,b   Esteban, Susana ^a,b   García Sevilla, Jesús A ^a,b  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b RETICS Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares Oftared   (Spain)

Author keywords

2 Auto and heteroreceptor; 5 HT1A auto and heteroreceptor; Cannabinoid addiction; CB1 receptors; Monoamine synthesis; Rat brain

Indexed keywords

2 DIBUTYLAMINO 8 HYDROXYTETRALIN; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 HYDROXYBENZYLHYDRAZINE; 5 HYDROXYTRYPTOPHAN; ALPHA 2 ADRENERGIC RECEPTOR; AUTORECEPTOR; BRAIN MONOAMINE; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CARBOXYLYASE; CLONIDINE; DOPA; DOPAMINE; NORADRENALIN; PRESYNAPTIC RECEPTOR; RIMONABANT; SEROTONIN; SEROTONIN 1A RECEPTOR;

ADDICTION; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CHRONIC DRUG ADMINISTRATION; CORPUS STRIATUM; DOPAMINE METABOLISM; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME INHIBITION; HIPPOCAMPUS; MALE; MONOAMINE METABOLISM; NEUROCHEMISTRY; NONHUMAN; NORADRENERGIC SYSTEM; RAT; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SEROTONINERGIC SYSTEM;

5-HYDROXYTRYPTOPHAN; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; AUTORECEPTORS; BENZOXAZINES; BIOGENIC MONOAMINES; BRAIN; CEREBELLUM; CORPUS STRIATUM; DIHYDROXYPHENYLALANINE; HIPPOCAMPUS; MALE; MORPHOLINES; NAPHTHALENES; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, CANNABINOID; SEROTONIN; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 59449084379     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-008-0337-0     Document Type: Article

References (78)

1. MD Aceto SM Scates BB Martin 2001 Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2 Eur J Pharmacol 416 75 81
2. A Ameri 1999 The effects of cannabinoids on the brain Prog Neurobiol 58 315 348
3. 1A receptor knockout mice J Neurochem 88 1373 1379
4. MM Bücheler K Hadamek L Hein 2002 Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C) inhibit transmitter release in the brain of gene-targeted mice Neuroscience 109 819 826
5. AK Cadogan SP Alexander EA Boyd DA Kendall 1997 Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum J Neurochem 69 1131 1137
6. A Carlsson JN Davis W Kehr M Lindqvist CV Atack 1972 Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase Naunyn- Schmiedeberg's Arch Pharmacol 275 153 168
7. A Castañé R Maldonado O Valverde 2004 Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice Br J Pharmacol 142 1309 1317
8. JF Cheer DA Kendall R Mason CA Marsden 2003 Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum Neuropharmacology 44 633 641
9. A Degroot GG Nomikos 2007 In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission Curr Op Pharmacol 7 62 68
10. N Egashira K Mishima S Katsurabayashi T Yoshitake Y Matsumoto J Ishida M Yamaguchi K Iwasaki M Fujiwara 2002 Involvement of 5-hydroxytryptamine neuronal system in delta(9)-tetrahydrocannabinol-induced impairment of spatial memory Eur J Pharmacol 445 221 229
11. N Egashira T Matsuda E Koushi K Mishima K Iwasaki Y Shoyama M Fujiwara 2006 Involvement of 5-hydroxytryptamine 1A receptors in Delta(9)- tetrahydrocannabinol-induced catalepsy-like immobilization in mice Eur J Pharmacol 550 117 122
12. 2-adrenoceptor subtypes Naunyn-Schmiedeberg's Arch Pharmacol 353 391 399
13. 1A autoreceptors regulating monoamine synthesis in the rat brain in vivo Naunyn-Schmiedeberg's Arch Pharmacol 360 135 143
14. 1A receptors modulating seroronine and dopamine synthesis in rat brain in vivo Neurosci Lett 326 121 124
15. 2 WIN 55,212-2 en cerebro de rata. Spanish Society for Neuroscience, XII Congress, Valencia, Abstract book, p 97
16. KB Fink M Göthert 2007 5-HT receptor regulation of neurotransmitter release Pharmacol Rev 59 360 417
17. 1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum J Neurophysiol 85 468 471
18. M Glass M Dragunow RL Faull 1997 Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain Neuroscience 77 299 318
19. MA Gorriti F Rodríguez de Fonseca M Navarro T Palomo 1999 Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats Eur J Pharmacol 365 133 142
20. M Häring G Marsicano B Lutz K Monory 2007 Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice Neuroscience 146 1212 1219
21. 2-Adrenoceptors are not involved in the regulation of striatal glutamate release: Comparison to dopaminergic inhibition J Neurosci Res 28 376 381
22. Y Hashimotodani T Ohno-Shosaku M Kano 2007 Endocannabinoids and synaptic function in the CNS Neuroscientist 13 127 137
23. M Herkenham AB Lynn MR Johnson LS Melvin BR de-Costa KC Rice 1991 Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J Neurosci 11 563 583
24. DM Hutcheson ET Tzavara C Smadja E Valjent BP Roques J Hanoune R Maldonado 1998 Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol Br J Pharmacol 125 1567 1577
25. 1A receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens Brain Res 858 252 263
26. K Inui N Egashira K Mishima A Yano Y Matsumoto N Hasebe K Abe K Hayakawa T Ikeda K Iwasaki M Fujiwara 2004 The serotonin1A receptor agonist 8-OHDPAT reverses delta 9-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats Neurotox Res 6 153 158
27. JJ Janoyan JL Crim NA Darmani 2002 Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids Pharmacol Biochem Behav 71 155 162
28. JD Jentsch E Andrusiak A Tran MB Bowers RH Roth 1997 Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966 Neuropsychopharmacology 16 426 432
29. 1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum J Pharmacol Exp Ther 266 133 141
30. M Kathmann U Bauer E Schlicker M Göthert 1999 Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain Naunyn-Schmiedeberg's Arch Pharmacol 359 466 470
31. 1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons J Neurosci 19 4544 4558
32. Y Kawahara H Kawahara BH Westerink 1999 Tonic regulation of the activity of noradrenergic neurons in the locus coeruleus of the conscious rat studied by dual-probe microdialysis Brain Res 823 42 48
33. B Kolb G Gorny CL Limebeer LA Parker 2006 Chronic treatment with Δ9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex Synapse 60 429 436
34. 1A receptors: Regional distribution and functional characteristics Nucl Med Biol 27 429 435
35. AH Lichtman BR Martin 1991 Cannabinoid-induced antinociception is mediated by a spinal alpha2-noradrenergic mechanism Brain Res 559 309 314
36. AH Lichtman BR Martin 2005
37. R-J Liu EK Lambe GK Aghajanian 2005 Somatodendritic autoreceptor regulation of serotonergic neurons: dependence on L-tryptophan and tryptophan hydroxylase-activating kinases Eur J Neurosci 21 945 958
38. R Maldonado F Rodríguez de Fonseca 2002 Cannabinoid addiction: behavioral models and neural correlates J Neurosci 22 3326 3331
39. R Maldonado O Valverde F Berrendero 2006 Involvement of the endocannabinoid system in drug addiction Trends Neurosci 29 225 232
40. DT Malone DA Taylor 1999 Modulation by fluoxetine of striatal dopamine release following delta(9)-tetrahydrocannabinol: a microdialysis study in conscious rats Br J Pharmacol 128 21 26
41. DT Malone DA Taylor 2001 Involvement of somatodendritic 5-HT(1A) receptors in delta(9)-tetrahydrocannabinol-induced hypothermia in the rat Pharmacol Biochem Behav 69 595 601
42. EM Marco L Pérez-Álvarez E Borcel M Rubio C Guaza E Ambrosio SE File MP Viveros 2004 Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats Behav Pharmacol 15 21 27
43. 1 receptors in rat brain slices Neurosci Lett 363 1 5
44. A Mendiguren J Pineda 2006 Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats Eur J Pharmacol 534 83 88
45. 1 receptors, on the in vivo activity of tyrosine amd tryptophan hydroxilase in the rat brain Naunyn-Schmiedeberg's Arch Pharmacol 369 516 524
46. D Moranta S Esteban JA García-Sevilla 2007 Acute, chronic and withdrawal effects of the cannabinoid receptor agonist WIN55212-2 on the sequential activation of MAPK/Raf-MEK-ERK signaling in the rat cerebral frontal cortex: short-term regulation by intrinsic and extrinsic pathways J Neurosci Res 85 656 667
47. AL Muntoni G Pillolla M Melis S Perra GL Gessa M Pistis 2006 Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons Eur J Neurosci 23 2385 2394
48. M Nakazi U Bauer T Nickel M Kathmann E Schlicker 2000 Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors Naunyn-Schmiedeberg's Arch Pharmacol 361 19 24
49. H Nissbrandt G Engberg M Wilkström T Magnusson A Carlsson 1988 NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors Naunyn-Schmiedeberg's Arch Pharmacol 338 148 161
50. VC Oropeza ME Page EJ Van Bockstaele 2005 Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex Brain Res 1046 45 54
51. ME Page VC Oropeza SE Sparks Y Qian AS Menko EJ Van Bockstaele 2007 Repeated cannabinoid administration increases indices of noradrenergic activity in rats Pharmacol Biochem Behav 86 162 168
52. ME Page VC Oropeza EJ Van Bockstaele 2008 Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex Neurosci Lett 431 1 5
53. D Parolaro D Viganò T Rubino 2005 Endocannabinoids and drug dependence Curr Drug Targets CNS Neurol Disord 4 643 655
54. RG Pertwee 1997 Pharmacology of cannabinoid CB1 and CB2 receptors Pharmacol Ther 74 129 180
55. 2-Autoreceptor- mediated modulation of tyrosine hydroxylase activity in noradrenergic regions of the rat brain in vivo Naunyn-Schmiedeberg's Arch Pharmacol 345 653 660
56. O Sagredo JA Ramos J Fernandez-Ruiz ML Rodriguez R de Miguel 2006 Chronic delta(9)-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex Naunyn-Schmiedeberg's Arch Pharmacol 372 313 317
57. 9-Tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons Neuroscience 151 320 328
58. A Sastre-Coll S Esteban JA García-Sevilla 1999 Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo Naunyn-Schmiedeberg's Arch Pharmacol 360 50 62
59. 2-adrenoceptors regulating monoamine synthesis in the brain of morphine-dependent rats Naunyn-Schmiedeberg's Arch Pharmacol 365 210 219
60. E Schlicker M Kathmann 2001 Modulation of transmitter release via presynaptic cannabinoid receptors Trends Pharmacol Sci 22 565 572
61. E Schlicker J Timm J Zentner M Göthert 1997 Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus Naunyn-Schmiedeberg's Arch Pharmacol 356 583 589
62. LJ Sim-Selley 2003 Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids Crit Rev Neurobiol 15 91 119
63. 1 receptor adaptation after cessation of long-term cannabinoid administration Mol Pharmacol 70 986 996
64. 2-adrenoceptors J Neurochem 78 685 693
65. K Starke M Göthert H Kilbinger 1989 Modulation of neurotransmitter release by presynaptic autoreceptors Physiol Rev 69 864 989
66. G Tanda SR Goldberg 2003 Cannabinoids: reward, dependence, and underlying mechanisms-a review of recent preclinica data Psychopharmacology 169 115 134
67. C Touriño R Maldonado O Valverde 2007 MDMA attenuates THC withdrawal syndrome in mice Psychopharmacology 193 75 84
68. AU Trendelenburg K Starke N Limberger 1994 Presynaptic alpha 2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices Naunyn-Schmiedeberg's Arch Pharmacol 350 473 481
69. AU Trendelenburg SL Cox V Schelb W Klebroff L Khairallah K Starke 2000 Modulation of (3)H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and beta-adrenoceptors in mouse tissues Br J Pharmacol 130 321 330
70. ET Tzavara KW Perry DE Rodriguez FP Bymaster GG Nomikos 2001 The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus Eur J Pharmacol 426 R3 R4
71. ET Tzavara RJ Davis KW Perry X Li C Salhoff FP Bymaster JM Witkin GG Nomikos 2003 The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions Br J Pharmacol 138 544 553
72. O Valverde 2005 Participation of the cannabionid system in the regulation of emotional-like behaviour Curr Pharm Des 11 3421 3429
73. O Valverde R Maldonado F Valjent AM Zimmer A Zimmer 2000 Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice J Neurosci 20 9284 9289
74. DJ Walther JU Peter S Bashammakh H Hörtnagl M Voits H Fink M Bader 2003 Synthesis of serotonin by a second tryptophan hydroxylase isoform Science 299 76
75. CT Wotjak 2005 Role of endogenous cannabinoids in cognition and emotionality Mini Rev Med Chem 5 659 670
76. D-F Wu L-Q Yang A Gorschke R Stumm L-O Brandenburg Y-J Liang V Höllt T Koch 2008 Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors J Neurochem 104 1132 1143
77. 2-adrenoceptor antagonist, augments the effects of L-DOPA on evoked dopamine release in rat striatum Eur J Pharmacol 462 83 89
78. X Zhang J-M Beaulieu TD Sotnikova RR Gainetdinov MG Caron 2004 Tryptophan hydroxylase-2 controls brain serotonin synthesis Science 305 217